Combining GLP-1 and HRT For many Dallas patients, using GLP-1 medications alongside HRT can be complementary
Even more notably, about a quarter of these women described their appetite reduction as "significant." 100% of the women in the Supresa group reported decreased hunger sensations Weight Management : While modest, the Supresa group showed statistically significant weight loss compared to placebo, losing 2.12 pounds over the 8-week period without any dietary restrictions
The only persistent side effect was appetite suppression, which is the intended therapeutic outcome
It's important to note that Rybelsus, being an oral formulation, does not cause injection site reactions
Finally, there is a need to leverage multimodal clinical data beyond structured EHR findings to truly understand the holistic impact of GLP-1s with outcomes captured from different types of structured and unstructured data